This article is part of the supplement: Lupus 2012: New targets, new approaches
Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus
- Equal contributors
Arthritis Research & Therapy 2012, 14(Suppl 3):A22 doi:10.1186/ar3956
Accesses
- Last 30 days: 38 accesses
- Last 365 days: 215 accesses
- All time: 215 accesses

